Decay-accelerating factor (CD55) promotes CD1d expression and Vγ4+ T-cell activation in Coxsackievirus B3-induced myocarditis

Viral Immunology

Volumn 19, Issue 2, 2006, Pages 156-166

  Huber, Sally ^a   Song, Wen Chao ^b   Sartini, Danielle ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECAY ACCELERATING FACTOR; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; T LYMPHOCYTE RECEPTOR V GAMMA 4; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; COXSACKIE VIRUS B3; COXSACKIE VIRUS INFECTION; DISEASE EXACERBATION; GENE OVEREXPRESSION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; KNOCKOUT GENE; KNOCKOUT MOUSE; LYMPHOCYTE COUNT; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN VARIANT; RECEPTOR AFFINITY; SPLEEN; T LYMPHOCYTE ACTIVATION; UPREGULATION; VIRUS MUTANT; VIRUS MYOCARDITIS; VIRUS TITRATION;

ANIMALS; ANTIGENS, CD1; ANTIGENS, CD55; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYOCARDITIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; UP-REGULATION;

ANIMALIA; COXSACKIEVIRUS;

EID: 33745906242     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.156     Document Type: Article

References (49)

1. Bergelson, J. M., J. F. Modlin, W. Wieland-Alter, J. A. Cunningham, R. L. Crowell, and R. W. Finberg. 1997. Clinical Coxsackievirus B isolates differ from laboratory strains in their interaction with two cell surface receptors. J Infect Dis 175: 697-700.
2. Bowles, N., P. Richardson, E. Olsen, and L. Archard. 1986. Detection of coxsackie B virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet I: 1120-1122.
3. Bowles, N. E., J. Ni, D. L. Kearney, M. Pauschinger, H. P. Schultheiss, R. McCarthy, J. Hare, J. T. Bricker, K. R. Bowles, and J. A. Towbin. 2003. Detection of viruses in myocardial tissues by polymerase chain reaction, evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42: 466-72.
4. Bowles, N. E., J. Ni, F. Marcus, and J. A. Towbin. 2002. The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 39: 892-5.
5. Brodbeck, W. G., L. Kuttner-Kondo, C. Mold, and M. E. Medof. 2000. Structure/function studies of human decay-accelerating factor. Immunology 101: 104-11.
6. Caron, G., D. Duluc, I. Fremaux, P. Jeannin, C. David, H. Gascan, and Y. Delneste. 2005. Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFNgamma production by memory CD4+ T cells. J Immunol 175: 1551-7.
7. Cheung, P. K., J. Yuan, H. M. Zhang, D. Chau, B. Yanagawa, A. Suarez, B. McManus, and D. Yang. 2005. Specific interactions of mouse organ proteins with the 5′untranslated region of Coxsackievirus B3: potential determinants of viral tissue tropism. J Med Virol 77: 414-24.
8. Davis, L. S., S. S. Patel, J. P. Atkinson, and P. E. Lipsky. 1988. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J Immunol 141: 2246-52.
9. Estrin, M., and S. Huber. 1987. Coxsackievirus B3-induced myocarditis. Autoimmunity is L3T4+ T helper cell and IL-2 independent in BALB/c mice. Am. J Pathol. 127: 335.
10. Feuer, R., I. Mena, R. Pagarigan, M. K. Slifka, and J. L. Whitton. 2002. Cell cycle status affects Coxsackievirus replication, persistence, and reactivation in vitro. J Virol 76: 4430-40.
11. Feuer, R., I. Mena, R. R. Pagarigan, D. E. Hassett, and J. L. Whitton. 2003. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency. Med Microbiol Immunol (Berl).
12. Gauntt, C., P. Sakkinen, N. Rose, and S. Huber. 2000. Picornaviruses: Immunopathology and autoimmunity. pp. 313-329, M. Cunningham, and R. Fujinami, eds. Effects of Microbes on the Immune System. Lippincott-Raven Publishers, Philadelphia.
13. Gelman, A. E., J. Zhang, Y. Choi, and L. A. Turka. 2004. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol 172: 6065-73.
14. Goodfellow, I. G., D. J. Evans, A. M. Blom, D. Kerrigan, J. S. Miners, B. P. Morgan, and O. B. Spiller. 2005. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol 79: 12016-24.
15. Guthrie, M., P. A. Lodge, and S. A. Huber. 1984. Cardiac injury in myocarditis induced by Coxsackievirus group B, type 3 in Balb/c mice is mediated by Lyt 2 + cytolytic lymphocytes. Cell Immunol 88: 558-67.
16. Harvala, H., H. Kalimo, J. Bergelson, G. Stanway, and T. Hyypia. 2005. Tissue tropism of recombinant Coxsackieviruses in an adult mouse model. J Gen Virol 86: 1897-907.
17. Heeger, P. S., P. N. Lalli, F. Lin, A. Valujskikh, J. Liu, N. Muqim, Y. Xu, and M. E. Medof. 2005. Decay-accelerating factor modulates induction of T cell immunity. J Exp Med 201: 1523-30.
18. Henke, A., S. Huber, A. Stelzner, and J. Whitton. 1995. The role of CD8 + T lymphocytes in Coxsackievirus B3-induced myocarditis. Journal of Virology 69: 6720-6728.
19. Huber, S. 1997. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Lab Invest 76: 691-701.
20. Huber, S. 1999. T cells expressing the gamma-delta T cell receptor regulate susceptibility in myocarditis and atherosclerosis. Current Medicine 2: 189-191.
21. Huber, S. 2000. T cells expressing the gamma-delta T cell receptor induce apoptosis in cardiac myocytes. Cardiovasc Res 45: 579-587.
22. Huber, S. 2004. T cells in Coxsackievirus induced myocarditis. Viral Immunology 17: 152-164.
23. Huber, S., D. Graveline, W. Born, and R. O'Brien. 2001. Cytokine Production by Vgamma+ T Cell Subsets is an Important Factor Determining CD4+ Th Cell Phenotype and Susceptibility of BALB/c mice to Coxsackievirus B3-Induced Myocarditis. J Virol 75: 5860-5868.
24. Huber, S., D. Graveline, M. Newell, W. Born, and R. O'Brien. 2000. Vgamma1+ T Cells Suppress and Vgamma4+ T Cells Promote Susceptibility to Coxsackievirus B3-Induced Myocarditis in Mice. J Immunol 165: 4174-4181.
25. Huber, S. and P. Lodge. 1984. Coxsackievirus B3 myocarditis in Balb/c mice: evidence for autoimmunity to myocyte antigens. Am. J. Path. 116: 21.
26. Huber, S. and P. Lodge. 1986. Coxsackievirus B3 myocarditis: identification of different mechanisms in DBA/2 and Balb/c mice. Am. J. Pathol. 122: 284.
27. Huber, S., A. Moraska, and M. Choate. 1992. T cells expressing the gamma delta T-cell receptor potentiate Coxsackievirus B3-induced myocarditis. J. Virol. 66.
28. Huber, S., D. Sartini, and M. Exley. 2003. Role of CD1d in Coxsackievirus B3-induced myocarditis. J Immunol 170: 3147-53.
29. Huber, S., C. Shi, and R. C. Budd. 2002. Gammadelta T cells promote a Th1 response during Coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol 76: 6487-94.
30. Huber, S. A. and B. Pfaeffle. 1994. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with Coxsackievirus group B type 3. J Virol 68: 5126-32.
31. Huber, S. A., and D. Sartini. 2005. Roles of tumor necrosis factor alpha (TNF-alpha) and the p55 TNF receptor in CD1d induction and Coxsackievirus B3-induced myocarditis. J Virol 79: 2659-65.
32. Huber, S. A., D. Sartini, and M. Exley. 2002. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in Coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells. J Virol 76: 10785-90.
33. Knowlton, K. U., E. S. Jeon, N. Berkley, R. Wessely, and S. Huber. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of Coxsackievirus B3. J Virol 70: 7811-8.
34. Lindberg, A., R. Crowell, R. Zell, R. Kandolf, and U. Pettersson. 1992. Mapping the RD phenotype of the Nancy strain of Coxsackievirus B3. Virus Res 24: 187-196.
35. Liu, J., T. Miwa, B. Hilliard, Y. Chen, J. D. Lambris, A. D. Wells, and W. C. Song. 2005. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo. J Exp Med 201: 567-77.
36. Loertscher, R., and P. Lavery. 2002. The role of glycosyl phosphatidyl inositol (GPI)-anchored cell surface proteins in T-cell activation. Transpl Immunol 9: 93-6.
37. Miwa, T., X. Sun, R. Ohta, N. Okada, C. L. Harris, B. P. Morgan, and W. C. Song. 2001. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. Immunology 104: 207-14.
38. Miwa, T., L. Zhou, B. Hilliard, H. Molina, and W. C. Song. 2002. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99: 3707-16.
39. Neumann, D., J. Lane, S. Wulff, G. Allen, A. Lafond-Walker, A. Herskowitz, and N. Rose. 1992. In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis. J Immunol 148: 3806-3811.
40. Pasch, A., J. H. Kupper, A. Wolde, R. Kandolf, and H. C. Selinka. 1999. Comparative analysis of virus host cell interactions of haemagglutinating and non-haemagglutinating strains of Coxsackievirus B3. J Gen Virol 80 (Pt 12): 3153-8.
41. Rueckert, R. 1996. Picronaviruses. Lippincott-Raven, Philadelphia, PA.
42. Selinka, H. C., A. Wolde, M. Sauter, R. Kandolf, and K. Klingel. 2004. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med Microbiol Immunol (Berl) 193: 127-31.
43. Shafren, D. 1998. Viral cell entry induced by cross-linked decay-accelerating factor. J Virol 72: 9407-9412.
44. Song, W. C., C. Deng, K. Raszmann, R. Moore, R. Newbold, J. A. McLachlan, and M. Negishi. 1996. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. J Immunol 157: 4166-72.
45. Sun, X., C. D. Funk, C. Deng, A. Sahu, J. D. Lambris, and W. C. Song. 1999. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc Natl Acad Sci U S A 96: 628-33.
46. Van Houten, N., P. Bouchard, A. Moraska, and S. Huber. 1991. Selection of an attenuated Coxsackievirus B3 variant using a monoclonal antibody reactive to myocyte antigen. J. Virol. 65: 1286-1290.
47. Weller, A., K. Simpson, M. Herzum, N. Van Houten, and S. Huber. 1989. Coxsackievirus B3 induced myocarditis: virus receptor antibodies modulate myocarditis. J Immunol 143: 1843-1850.
48. Yanagawa, B., O. B. Spiller, J. Choy, H. Luo, P. Cheung, H. M. Zhang, I. G. Goodfellow, D. J. Evans, A. Suarez, D. Yang, and B. M. McManus. 2003. Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice. Lab Invest 83: 75-85.
49. Yanagawa, B., O. B. Spiller, D. G. Proctor, J. Choy, H. Luo, H. M. Zhang, A. Suarez, D. Yang, and B. M. McManus. 2004. Soluble recombinant Coxsackievirus and adenovirus receptor abrogates Coxsackievirus b3-mediated pancreatitis and myocarditis in mice. J Infect Dis 189: 1431-9.